Nasze ostatnie realizacje
International Forum on Tuberculosis in Central and Eastern Europe
4TH – 6TH November 2016 Warsaw, Poland
It is my sincere pleasure to invite you to the 1st International Forum on Tuberculosis in Central and Eastern Europe, which will take place in Warsaw, Poland, from 4th to 6thNovember 2016.
Tuberculosis (TB) has plagued mankind for centuries. It still continues to be a significant health problem throughout the world. With a death toll of 2 million people every year, TB ranks first as the cause of death among all infectious diseases known to afflict human population worldwide, surpassing even HIV/AIDS, malaria or influenza.
One of the main reasons for the persistence of the disease is resistance of its etiological agent – Mycobacterium tuberculosis – to anti-TB drugs currently in use. Of particular concern is multidrug resistance, defined as resistance of tubercle bacilli to at least isoniazid and rifampicin, the two most potent anti-TB drugs. More disturbingly, extensively drug-resistant (XDR) and totally drug-resistant (TDR) TB phenotypes have recently been described, leaving patients with virtually no treatment options available. Much of the global burden of drug-resistant TB has been borne by the Central and Eastern Europe, at the juncture of the European and Asian continents. Consequently, this part of the world has been a hotspot for drug-resistant TB, and scrupulous monitoring of TB caseload in this region is of utmost importance.
To better recognize the extent and dynamics of drug resistance in tubercle bacilli, and to understand the molecular mechanisms underlying this resistance, allowing the identification of potential targets for novel anti-TB drugs, a wider and more concerted, international action is needed.
In recognition of this need for enhanced attention to the global TB epidemic through the joint efforts of the Polish Society of Microbiologists and the University of Warsaw’s Faculty of Biology, with the generous financial support of the Polish Ministry of Science and Higher Education, an exceptional conference dedicated to the epidemiology of TB in Central and Eastern Europe, with particular emphasis on drug-resistance, was organized.
During the conference, leading TB experts from across the whole region will outline the epidemiological landscape of the disease in different countries with relation to the latest clinical and diagnostic achievements. Furthermore, international institutions and organizations involved in the TB control and surveillance activities, along with local TB laboratory networks will be presented.
The purpose of the conference is threefold. Firstly, it has an important educational and popularizing role, by discussing a wide array of TB epidemiology-related issues, and thereby spreading the public awareness of the disease and its global impact, as well as increasing understanding of the relevance of TB research and their implementation in technological devices. Secondly, I firmly believe that the conference will allow all TB professionals to share their experience, ideas and innovations in the routine clinical and diagnostic practice, transmitting this knowledge also to non-expert audience. Thirdly, it is my very ambitious hope that the conference will provide a unique opportunity for the delegates from different European countries to develop a coherent vision for a close scientific collaboration, which could lead to the establishment of an international consortium aiming at prioritizing, integrating and synergizing the research endeavors undertaken in the field of TB in Central and Eastern Europe.
I am convinced that the scientific programme of the conference will prove itself to be of great interest to all attendees, and will encourage a vivid dialogue among them in both formal and informal settings.
I also hope that all the guests will have, during their stay, a chance to take advantage of some cultural, social or sightseeing opportunities offered by Warsaw, a capital of Poland, a city with seven-century tradition and rich and heroic history.
I look forward to welcoming you to Warsaw.
Dr. Tomasz Jagielski